VEGFA and rheumatoid arthritis: Our results may be consistent with the previous experimental studies, which revealed that digoxin may possess anti-angiogenic properties through suppression of the angiogenic markers HIF-1α and VEGF, suggesting that digoxin may have potential antiangiogenic properties in RA patients and exert its therapeutic effects through HIF-1α/VEGF axis suppression.